Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

University of California, Santa Barbara, 3227 Cheadle Hall, Santa Barbara, CA 93106-0001

UEI: SLED_FB3713AB1C316B4D

University of California, Santa Barbara, 3227 Cheadle Hall, Santa Barbara, CA 93106-0001 is a federal contractor, registered under UEI SLED_FB3713AB1C316B4D. It has been awarded $65,580,000 across 1 federal contract. Primary work spans Research and Development in Biotechnology. Top awarding agencies include W6QK Acc-Apg Durham.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_FB3713AB1C316B4D

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

W6QK Acc-Apg Durham$65.6M100%

Awards by NAICS

541711 - Research and Development in Biotechnology$65.6M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in University of California, Santa Barbara, 3227 Cheadle Hall, Santa Barbara, CA 93106-0001's top NAICS codes and agencies

Genome-Edited iPSC Line Generation for Alzheimer’s & ADRD ModelsThis subcontract, issued by the National Institutes of Health Olao under the Department of Health and Human Services, focuses on the generation of genetically engineered human induced pluripotent stem cell lines for research into Alzheimer’s Disease-Related Dementias. The project specifically requires the use of the ONE-STEP tagging system to create disease-relevant lines, including the insertion of attP sites. The performance of this contract is centered in Bethesda, with a NAICS code of 541711. The solicitation was posted on August 17, 2026, with a response deadline of August 21, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

Technical Data Acquisition & Reverse EngineeringThis subcontract opportunity, issued by the Department of Defense through the Ok DLA Aviation At Oklahoma City, focuses on the technical data acquisition and reverse engineering of engineering drawings and technical specifications. The primary objective is the independent procurement of these materials, with a specific requirement for reverse engineering services in instances where an Engineering Data List is unavailable. The project falls under NAICS code 541711 and was posted on August 12, 2026. Interested parties must submit their responses by the deadline of August 20, 2026, at 04:59:00 UTC.

Ok DLA Aviation At Oklahoma City

POSTED

DEADLINE

in about 24 hours

Data Collection & Analytics for Lunar MissionsThe National Aeronautics And Space Administration, specifically the Space Operations Mission Directorate, is seeking a subcontractor to develop data collection frameworks and analytical models focused on health metrics. This initiative is designed to monitor and analyze astronaut health during lunar missions ranging from short-duration stays to month-long deployments. The opportunity was posted on August 11, 2026, with a response deadline of September 8, 2026. Classified under NAICS code 541711, the project emphasizes the creation of robust systems to ensure the well-being of crew members during extended lunar operations.

Space Operations Mission Directorate

POSTED

DEADLINE

Pharmaceutical-Based Agent (PBA) Detection Systems

POSTED

DEADLINE

Dose Formulation and Compound Handling

National Institutes Of Health Olao

POSTED

DEADLINE

Integrated Phase I/II Clinical Trial DesignThe contract seeks the design and protocol development for an integrated Phase I/II clinical trial to evaluate ibogaine as a potential treatment for opioid use disorder, focusing on safety, optimal dosing, and therapeutic efficacy. The effort requires a comprehensive clinical framework that seamlessly merges the objectives of Phase I, which prioritizes dose escalation and toxicity profiling, with those of Phase II, which assesses preliminary effectiveness in reducing opioid dependence and withdrawal symptoms. The protocol must adhere to rigorous scientific and regulatory standards, incorporating appropriate patient selection criteria, monitoring procedures, endpoints, and risk mitigation strategies for a substance with significant pharmacological and safety considerations. The work is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code indicating research and development in the life sciences. The solicitation was posted on August 5, 2026, and responses are due by October 15, 2026. The project is situated within a broader initiative to advance novel therapeutic interventions for the opioid crisis, requiring innovative trial design that balances exploratory research with clinical feasibility. There is no specified set-aside designation or location restriction for performance, indicating flexibility in execution while emphasizing scientific merit and regulatory alignment as key evaluation criteria.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

in about 2 months

Phage-Based Formulation Development

W6QK Acc Ccdc Sttc

POSTED

DEADLINE

High-Throughput Yeast Two-Hybrid ScreeningA large-scale yeast two-hybrid screening project is being sought to identify protein-protein interactions between viral bait proteins and aphid prey libraries, encompassing all necessary laboratory procedures including yeast transformation and interaction assays. The effort is designed to enable high-throughput discovery of molecular connections critical to understanding viral infection dynamics in aphid hosts, with the goal of advancing agricultural pest and disease control strategies. This subcontract is designated as a Small Business Set Aside under NAICS code 541711, reserved exclusively for small business concerns, and is managed by the USDA Agricultural Research Service through its Albany Facility. The opportunity was posted on August 4, 2026, with a firm response deadline of August 28, 2026, and the performance location is specified as Ithaca, New York, with a zip code of 14853. The contract type and set-aside status emphasize support for small business participation in federally funded scientific research aimed at improving agricultural outcomes.

USDA Ars Afm Apd

POSTED

DEADLINE

Aphid cDNA Prey Library DevelopmentThe contract involves the development of a normalized cDNA library from aphid RNA supplied by the government, specifically for use in yeast two-hybrid prey systems. The work includes reverse transcription of the RNA into complementary DNA and subsequent cloning procedures to generate a high-quality, representative library that enables effective protein-protein interaction screening. The project is designed to support biological research efforts by providing a standardized, scalable prey library that enhances the reliability and depth of interaction data in functional genomics studies. This subcontract is designated as a Small Business Set Aside under the NAICS code 541711, indicating it is reserved for small businesses engaged in research and development in the life sciences. The work is to be performed in Ithaca, New York, with a response deadline of August 28, 2026, and was posted on August 4, 2026. The contracting entity is the USDA Agricultural Research Service, Agricultural Facilities Management and Application Personnel Division, and the project is intended to advance USDA’s mission in agricultural biotechnology and pest research through innovative molecular tools.

USDA Ars Afm Apd

POSTED

DEADLINE

Viral Bait Clone ConstructionThe contract involves the design and molecular cloning of viral protein bait constructs specifically for use in yeast two-hybrid systems, requiring comprehensive molecular biology expertise including codon optimization for host compatibility, precise plasmid insertion, and rigorous sequence validation to ensure accuracy and functionality. The work focuses on creating reliable protein baits that enable the study of virus-host protein interactions, which is critical for understanding pathogenic mechanisms and identifying potential therapeutic targets. All constructs must meet high standards of precision to support downstream functional assays in a controlled laboratory environment. The contract is designated as a Small Business Set Aside under NAICS code 541711 for scientific research and development, with performance to be carried out in Ithaca, New York, at the USDA ARS AFM APD facility. It was posted on August 4, 2026, and responses are due by August 28, 2026, with a clear emphasis on delivering technically robust and validated molecular reagents within the specified timeframe. The scope demands a high level of technical proficiency in molecular cloning, sequence analysis, and bioinformatics tools, with deliverables expected to support ongoing virology and host-pathogen interaction research funded by the U.S. Department of Agriculture.

USDA Ars Afm Apd

POSTED

DEADLINE

SOURCES SOUGHT FOR COOPERATIVE RESEARCH & DEVELOPMENT PARTNERSHIPS HYPERSONIC INFRARED TARGET SENSING – TRANSITION OPPORTUNITY (HITS-TO)

Solicitation # W911NF-26-HITS-TO

The U.S. Department of Defense is seeking potential partners in industry, national laboratories, University Affiliated Research Centers, and Federally Funded Research and Development Centers to establish Cooperative Research and Development Agreements focused on advancing hypersonic infrared target sensing technologies. The initiative, designated HITS-TO, aims to accelerate the development and transition of transformative innovations that enable the integration of high-performance infrared seekers onto hypersonic weapons systems. This effort is driven by the urgent need to close capability gaps in hypersonic defense and offense, leveraging the expertise of external entities to complement existing DoD laboratory research. Participation is non-funded; the notice serves solely to identify willing and capable collaborators to form partnerships that will jointly develop and mature critical technologies without monetary support from the government. The solicitation, identified as W911NF-26-HITS-TO, was officially posted on July 9, 2026, with responses required by September 30, 2026. The activity is managed by the Office of W6QK Acc-Apg Durham under the Department of Defense, with correspondence directed to HITS_RFI@army.mil. The point of contact and administrative operations are based in Research Triangle Park, North Carolina. While no funding is offered through this sources-sought notice, successful partnerships may lead to future agreements enabling joint development, resource sharing, and accelerated technology maturation for national defense priorities in the hypersonic domain.

W6QK Acc-Apg Durham

POSTED

DEADLINE

in about 1 month

Trusted Partner Program Coming Soon

Solicitation # W911NF26RA009

The U.S. Army, through the Army Research Office and the Office of Contracting at Research Triangle Park, North Carolina, is issuing a presolicitation for the Trusted Partner Program, a multiple-award IDIQ contract aimed at establishing a cadre of trusted academic partners—including institutions of higher education and their affiliated entities—to conduct rapid, sensitive basic and applied scientific research in support of national defense priorities. The solicitation, numbered W911NF26RA009, targets research in Scaled Directed Energy and Scaled Hypersonics, requiring multidisciplinary expertise across physics, electronics, chemistry, materials science, information sciences, and biology, with an emphasis on integrating these fields to address complex Army needs. The base performance period is five years, beginning September 2026, with an optional five-year extension, bringing the total potential contract value to $400 million, with individual task orders to be issued under cost-plus-fixed-fee or firm-fixed-price arrangements. Offerors must submit proposals in five separate volumes, each as a searchable PDF, along with a supplemental unclassified video pitch between three and seven minutes in length, formatted in MPEG-4 at 1080p resolution. Proposals are due by 4:00 PM Eastern Time on July 15, 2026, and must be emailed to the designated point of contact. Evaluation will be conducted based on five factors, ranked in order of importance: Technical (most important), Management, Past Performance, Small Business, and Cost & Business Structure (least important non-cost factor). No numerical weights are assigned, and the award will be made using a trade-off process emphasizing superior technical merit over price, with the expectation that all non-cost factors combined carry significantly greater weight than cost. The Technical factor includes equally weighted subfactors centered on expertise in six core disciplines and six critical interdisciplinary projects, assessed using adjectival ratings from BLUE (outstanding, low risk) to RED (unacceptable, unawardable). Compliance with regulatory requirements is strict: contractors must maintain active UEI and CAGE codes in SAM, adhere to cybersecurity maturity model certification requirements, and submit all deliverables in accordance with Department of Transportation packaging standards and marking requirements that include contract number, project title, and sensitive data classification. Travel is highly regulated, requiring prior COR approval and adherence to JTR per diem limits; OCONUS travel necessitates SPOT registration and a Letter of Authorization. Organizational conflicts of interest will be rigorously assessed, and all

W6QK Acc-Apg Durham

POSTED

DEADLINE

Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

Access Denied: Subcontract Opportunities Not AvailableAccess to the contract details is restricted due to authentication failures, preventing retrieval of the prime contract information, Statement of Work, CLINs, or other essential data required to analyze subcontract or supplier opportunities. The solicitation is identified as a subcontract under the Department of Defense, with the performing office listed as W6QK Acc-Apg Durham, but no specific location, point of contact, or set-aside information is available. The posting date is July 9, 2026, and the response deadline is September 30, 2026, though no NAICS code or organization type is provided. The opportunity remains inaccessible without proper credentials to view the underlying contract terms or requirements.

W6QK Acc-Apg Durham

POSTED

about 1 month ago

DEADLINE

in about 1 month

Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 2 months ago

DEADLINE

in about 1 month

Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 2 months ago

DEADLINE

in about 1 month

Biographical and Key Personnel SupportThe contract entails the preparation of biographical sketches, curriculum vitae, and supporting documentation for key personnel to meet U.S. Department of Defense research proposal compliance standards. The work focuses on ensuring all materials align with DoD formatting, content, and submission requirements for critical personnel involved in proposed research initiatives. This subcontract supports the acquisition process by providing professionally crafted and standardized documentation that enhances the credibility and competitiveness of DoD-funded research applications. The solicitation, issued under NAICS code 541611, is managed by the Department of Defense through the W6QK Acc-Apg Durham office, with performance required in Durham, North Carolina, specifically at ZIP code 27707. The response deadline is set for November 21, 2027, at 4:59 a.m. Eastern Time, providing a window of over a year for potential subcontractors to prepare and submit proposals. The contract does not specify a set-aside type or organization type restrictions and is issued through the Federal Procurement Data System, with additional information accessible via the provided SAM.gov link.

W6QK Acc-Apg Durham

POSTED

about 2 months ago

DEADLINE

Research and Development Technical Support ServicesThe contract awards technical support services for scientific research and development under U.S. Department of Defense funding, focusing on the execution of R&D tasks such as prototyping, computational modeling, data collection, analysis, and comprehensive reporting. The work is to be performed in Durham, North Carolina, with a performance deadline set for November 21, 2027, and bids are due by that date and time. The contract is structured as a subcontract and falls under NAICS code 541715, which classifies it as research and development in the physical, engineering, and life sciences. The contracting activity is managed by the W6QK Acc-Apg Durham office under the Department of Defense, and while no specific set-aside designation is indicated, the nature of the work requires specialized scientific and technical expertise. Contractors are expected to deliver high-quality, mission-critical research outputs aligned with DoD objectives, with all activities centered around advancing technological capabilities through rigorous scientific methods. No point of contact information is provided, and further inquiries must be directed through the official SAM.gov portal linked in the posting.

W6QK Acc-Apg Durham

POSTED

about 2 months ago

DEADLINE